Contact
Please use this form to send email to PR contact of this press release:
AffaMed Therapeutics Announces Merger with EverInsight Therapeutics and Appoints Dayao Zhao, M.D., Ph.D. as CEO
TO:
Edmond Lococo
ICR Asia
+86 138 1079 1408